SGMO - Sangamo Therapeutics GAAP EPS of -$0.32 beats by $0.04 revenue of $27.23M beats by $0.37M February, 22 2023 05:28 PM Sangamo Therapeutics Inc. Sangamo Therapeutics press release ( NASDAQ: SGMO ): Q4 GAAP EPS of -$0.32 beats by $0.04 . Revenue of $27.23M (-2.8% Y/Y) beats by $0.37M . For further details see: Sangamo Therapeutics GAAP EPS of -$0.32 beats by $0.04, revenue of $27.23M beats by $0.37M